Epilepsy Trial, Recruiting NCT06924086 Sponsor: University College, London Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06924086
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are between 5 and 14 years old at the time of consent
  • Children who have been diagnosed with Lennox-Gastaut Syndrome (LGS), confirmed by a specific abnormal brain wave pattern seen on a brainwave test (EEG) at least six months before the study starts
  • Children who have a history of drop seizures (where the body suddenly stiffens, goes limp, or convulses) that began at least six months before the study starts
  • Children who have had at least 10 seizures in the four weeks before joining the study
  • Children who have already tried two or more seizure medications without those medications working well enough
  • Children who are currently taking one or more seizure medications at a consistent, unchanged dose for at least the four weeks before joining
  • Children whose carer is willing to keep the child's seizure medications and ketogenic diet (if the child follows one) unchanged for the entire duration of the trial
  • Children whose carer is willing and able to follow all study requirements, including filling in a seizure diary and regularly charging a medical device

Who may not be able to join:

  • Children who have previously had a deep brain stimulation (DBS) device surgically inserted
  • Children who have an active vagus nerve stimulator (a device that sends signals to the brain via a nerve in the neck), or who had one switched on within the six months before the study baseline period
  • Children whose seizure medication has been changed or stopped within the last four weeks
  • Children whose ketogenic diet was started or changed within the last 12 weeks
  • Children whose brain scans show an abnormality in a specific part of the brain (the thalamus) that would make deep brain stimulation unsafe or not possible
  • Children who have a bleeding disorder
  • Children who have a medical condition that would make the risks of general anaesthesia too high (confirm with trial site)
  • Children who have a nickel allergy
  • Children who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +44 20 7405 9200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 March 2026
Est. completion
31 January 2028

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Seizure frequency reduction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov